| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/03/1993 | EP0529622A2 Cloning and characterization of a cardiac adenylyl cyclase |
| 03/03/1993 | EP0529584A2 Viral agent associated with the Mystery Swine Disease |
| 03/03/1993 | EP0529033A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 03/03/1993 | EP0529023A1 Therapeutically useful peptides and peptides fragments |
| 03/03/1993 | EP0529007A1 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION |
| 03/03/1993 | EP0528951A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
| 03/03/1993 | EP0528931A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
| 03/03/1993 | EP0528926A1 Soluble peptide analogues containing binding sites |
| 03/03/1993 | EP0528859A1 Oral vaccine comprising antigen surface-associated with red blood cells |
| 03/03/1993 | EP0528835A1 Cyclic peptides and their use |
| 03/03/1993 | EP0528787A1 A method for isolating and purifying transferrin and lactoferrin receptor proteins from bacteria and the preparation of vaccines containing the same |
| 03/03/1993 | EP0318498B1 Human b lymphotropic virus (hblv) isolation and products |
| 03/03/1993 | EP0211013B1 Immunotherapeutic methods and compositions employing antigenes characteristic of malignant neoplasms |
| 03/03/1993 | EP0127681B1 Iga binding protein |
| 03/03/1993 | CN1069522A Intercellular adhesion molecule-3 and its binding ligands |
| 03/03/1993 | CN1019979C Method for removing pertussis endoxin |
| 03/02/1993 | US5191015 Polymers and polymer-peptide conjugates |
| 03/02/1993 | US5190752 Intravenously administerable polyclonal immunoglobulin preparation containing igm and method of manufacture |
| 03/01/1993 | WO1993005152A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2094242A1 Antibodies to streptolysin o derivatives and variants |
| 03/01/1993 | CA2076995A1 Cloning and characterization of a cardiac adenylyl cyclase |
| 02/27/1993 | CA2076903A1 Recombinant fowlpox virus |
| 02/24/1993 | EP0528767A1 Antibody derivatives |
| 02/24/1993 | EP0528527A2 Conjugates |
| 02/24/1993 | EP0528011A1 CD4-GAMMA2 AND CD4-IgG2 CHIMERAS |
| 02/24/1993 | EP0528007A1 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF $g(b) CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/24/1993 | EP0527823A1 Purification, detection and methods of use of protease nexin-2 |
| 02/24/1993 | EP0527815A1 Hepatitis c virus epitopes |
| 02/24/1993 | EP0527789A1 Hiv envelope polypeptides |
| 02/24/1993 | EP0527786A1 Purified hcv and hcv proteins and peptides |
| 02/24/1993 | EP0527785A1 Improvements relating to the detection of viruses |
| 02/24/1993 | EP0527771A1 Polypeptides useful in diagnosis of and treatment against mycoplasma infections in animals |
| 02/24/1993 | EP0527767A1 Self-polymerising expression system based on modified potyvirus coat proteins |
| 02/24/1993 | EP0527752A1 Expression of heterologous protein in yeast |
| 02/23/1993 | WO1993004090A1 Hiv immunotherapeutics |
| 02/23/1993 | US5189147 Meterodimeric T lymphocyte receptor antibody |
| 02/23/1993 | US5189028 Composition and method to enhance the efficacy of a fish vaccine and to stimulate the immune system of fish |
| 02/23/1993 | CA1313820C High titer anti-respiratory syncytial virus intravenous immune globulin |
| 02/18/1993 | WO1993003158A1 System for protein expression and secretion especially in corynebacteria |
| 02/18/1993 | WO1993003148A2 Tau/neurofilament protein kinases pk40 and pk36 |
| 02/18/1993 | WO1993003146A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | WO1993003145A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 02/18/1993 | WO1993003057A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | WO1993003050A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | WO1993002706A1 Self-adjuvanting peptide vaccine delivery system and production thereof |
| 02/18/1993 | WO1993002705A1 Method for inhibiting blood coagulant activity |
| 02/18/1993 | WO1993002704A1 Mixture of peptide constituents having vaccinating properties against paludism particularly due to plasmodium falciparum |
| 02/18/1993 | WO1993002703A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | WO1993002702A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/18/1993 | WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 02/18/1993 | WO1993002690A1 Diagnosis and treatment of autoimmune diseases |
| 02/18/1993 | WO1993002556A1 Cancer therapy utilizing malignant cells |
| 02/18/1993 | CA2114942A1 Novel cyclophilins, associating proteins and uses |
| 02/18/1993 | CA2114934A1 Prodrugs activated by targeted catalytic proteins |
| 02/18/1993 | CA2114647A1 Diagnosis and treatment of autoimmune diseases |
| 02/18/1993 | CA2114223A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p. falciparum, related products and their use in producing vaccine compositions |
| 02/18/1993 | CA2114125A1 Self-adjuvanting peptide vaccine delivery system and production thereof |
| 02/18/1993 | CA2113990A1 Cancer therapy utilizing malignant cells |
| 02/18/1993 | CA2113280A1 Disease associated b-cell epitopes of tpo and use thereof |
| 02/18/1993 | CA2110505A1 Infectious bursal disease virus recombinant poxvirus vaccine |
| 02/18/1993 | CA2083273A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
| 02/17/1993 | CN1069124A Antibodies and method for their use |
| 02/17/1993 | CN1069068A Recombinant avipox virus, culture of cells infected by this virus and vaccines for poultry derived from this virus |
| 02/16/1993 | US5187090 For tumor diagnosis |
| 02/16/1993 | US5187087 Recominbant herpesvirus of turkeys and live vector vaccines derived thereof |
| 02/16/1993 | US5187080 For inducing immune response in chickens |
| 02/16/1993 | US5187063 Combining a muscle sample with antibodies which specifically bind to glycoprotein component of dystrophin/glycoprotein complex, detecing extent of binding and comparing with extent of binding in nondystrophic muscle tissue samples |
| 02/16/1993 | US5186933 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
| 02/16/1993 | US5186513 Softshell |
| 02/11/1993 | DE4126484A1 Anti-sense-RNA expression vectors - contain hybrid promoter sequences and viral DNA sequences i.e. HIV, in anti-sense direction, useful in prodn. of HIV-resistant cells |
| 02/10/1993 | EP0526953A1 Multichain polypeptides or proteins and processes for their production |
| 02/10/1993 | EP0526888A2 Monoclonal antibody reactive with human pancreas cancer tissue |
| 02/10/1993 | EP0526700A2 Drug-containing protein-bonded liposome |
| 02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
| 02/10/1993 | EP0403524B1 Preparation of nitruro compounds usable as radio-pharmaceutical products |
| 02/10/1993 | EP0402415B1 Synthetic scm-active cancer recognition peptides |
| 02/10/1993 | EP0396563B1 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
| 02/10/1993 | CA2075611A1 Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody, and detection systems |
| 02/09/1993 | US5185441 Polypeptides that bind to CD2, the receptor on the surface of T-cells |
| 02/09/1993 | US5185440 cDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereof |
| 02/09/1993 | US5185432 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
| 02/09/1993 | US5185321 Adding lysozyme to Lactobeicillus, incubating, hydrolyzing peptidoglycans, centriguging, adding to whey or fermented milk |
| 02/09/1993 | US5185319 Administering a mixture of insulin and a 30hydroxypyrid-4-one |
| 02/09/1993 | US5185254 Gene family of tumor-associated antigens |
| 02/09/1993 | US5185147 Protein is not one found in naturally occurring human immunodeficiency virus or other animal virus |
| 02/09/1993 | US5185146 Recombinant mva vaccinia virus |
| 02/09/1993 | CA2014033C Compositions and treatments for pneumonia in animals |
| 02/08/1993 | CA2048562A1 Salt stabilization of antibody-enzyme conjugates heat-dried into paper |
| 02/07/1993 | CA2075343A1 Monoclonal antibody and uses of the same |
| 02/04/1993 | WO1993002192A1 Modified pf4 compositions and methods of use |
| 02/04/1993 | WO1993002191A1 Humanized antibody against cd18 |
| 02/04/1993 | WO1993002190A1 Production of antibodies |
| 02/04/1993 | WO1993002184A1 Papilloma virus vaccine |
| 02/04/1993 | WO1993002108A1 Recombinant antibodies for human therapy |
| 02/04/1993 | WO1993002106A1 Neural calcium-activated neutral proteinase inhibitors |
| 02/04/1993 | WO1993002104A1 Recombinant infectious bovine rhinotracheitis virus |
| 02/04/1993 | WO1993002102A1 Novel peptide antigens and immunoassays, test kits and vaccines using the same |
| 02/04/1993 | WO1993001835A1 Stabilized human monoclonal antibody preparation |
| 02/04/1993 | WO1993001833A1 Improved vaccine |
| 02/04/1993 | WO1993001831A1 Induction of cytotoxic t-lymphocyte responses |